Network Feed
What’s In A Name? Maybe A Serious Side Effect
Three years ago, Johnson & Johnson changed the name of its Alzheimer’s drug Reminyl after it was confused with a diabetes med, Amaryl. Mix-ups were linked to two deaths and serious health problems. Changing the name of a drug already on the market is unusual, but the case highlights a growing dilemma that similar names [...] Complete Story.
11ENDORSEMENTSAcurian Beefs Up Data Modeling Capabilities for Patient Recruitment
Patient recruitment provider Acurian is increasing its data modeling capabilities, a move that chief information officer and vice president of operations Roger Smith says benefits not just Acurian but the entire industry. “Too many sponsors are forced to rely on... Complete Story.
11ENDORSEMENTSParexel Closes The Acquisition Of Clinphone
PAREXEL International Corporation (NASDAQ: PRXL), a global biopharmaceutical services organization,
today announced the successful closing of the acquisition of ClinPhone plc, a clinical technology
organization. Complete Story.
Parexel Finalizes ClinPhone Acquisition
Contract research organization (CRO) Parexel International has finalized the acquisition of UK-based clinical technology firm ClinPhone. ClinPhone and Perceptive Informatics, Parexel’s existing technology subsidiary, will combine to provide enhanced eClinical services and products, according to a Parexel statement released today.... Complete Story.
9ENDORSEMENTS